Obesity activates toll-like receptor-mediated proinflammatory signaling cascades in the adipose tissue of mice

Journal of Nutritional Biochemistry

Volumn 23, Issue 2, 2012, Pages 113-122

  Kim, Seung Jin ^a   Choi, Youngshim ^a   Choi, Youn Hee ^b   Park, Taesun ^a  

^a Yonsei University   (South Korea)

^b Ewha Womans University School of Medicine   (South Korea)

Author keywords

Adipose fat depot; High fat diet; Inflammation; Ob ob mice; Toll like receptors

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON REGULATORY FACTOR; LEPTIN; MYELOID DIFFERENTIATION FACTOR 88; STAT1 PROTEIN; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 11; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY FAT; CHRONIC INFLAMMATION; CONTROLLED STUDY; EPIDIDYMIS FAT; LIPID DIET; MALE; METAFLAMMATION; MOUSE; NONHUMAN; OBESITY; PROTEIN EXPRESSION; PROTEIN INDUCTION; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; SUBCUTANEOUS FAT; UPREGULATION;

ADIPOSE TISSUE; ANIMALS; CYTOKINES; DIET, HIGH-FAT; GENE EXPRESSION REGULATION; INFLAMMATION; MALE; MICE; MICE, INBRED C57BL; MICE, OBESE; NF-KAPPA B; OBESITY; PHENOTYPE; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS; TRANSCRIPTION FACTORS;

MURINAE; MUS;

EID: 84855508991     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2010.10.012     Document Type: Article

References (64)

1. Schaffler A., Muller-Ladner U., Scholmerich J., Buchler C. Role of adipose tissue as an inflammatory organ in human diseases. Endocr Rev 2006, 27:449-467.
2. Hotamisligil G.S. Inflammation and metabolic disorders. Nature 2006, 444:860-867.
3. Kahn B.B., Flier J.S. Obesity and insulin resistance. J Clin Invest 2000, 106:473-481.
4. Wellen K.E., Hotamisligil G.S. Obesity-induced inflammatory changes in adipose tissue. J Clin Invest 2003, 112:1785-1788.
5. Juge-Aubry C.E., Somm E., Chicheportiche R., Burger D., Pernin A., Cuenod-Pittet B., et al. Regulatory effects of interleukin (IL)-1, interferon-beta, and IL-4 on the production of IL-1 receptor antagonist by human adipose tissue. J Clin Endocrinol Metab 2004, 89:2652-2658.
6. Bunout D., Munoz C., Lopez M., de la Maza M.P., Schlesinger L., Hirsch S., et al. Interleukin 1 and tumor necrosis factor in obese alcoholics compared with normal-weight patients. Am J Clin Nutr 1996, 63:373-376.
7. Boden G., She P., Mozzoli M., Cheung P., Gumireddy K., Reddy P., et al. Free fatty acids produce insulin resistance and activate the proinflammatory nuclear factor-kappaB pathway in rat liver. Diabetes 2005, 54:3458-3465.
8. Ajuwon K.M., Spurlock M.E. Palmitate activates the NF-kappaB transcription factor and induces IL-6 and TNFalpha expression in 3T3-L1 adipocytes. J Nutr 2005, 135:1841-1846.
9. Medzhitov R. Toll-like receptors and innate immunity. Nat Rev Immunol 2001, 1:135-145.
10. Akira S., Takeda K., Kaisho T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol 2001, 2:675-680.
11. Takeda K., Akira S. Toll-like receptors in innate immunity. Int Immunol 2005, 17:1-14.
12. Hwa Cho H., Bae Y.C., Jung J.S. Role of toll-like receptors on human adipose-derived stromal cells. Stem Cells 2006, 24:2744-2752.
13. Kopp A., Buechler C., Neumeier M., Weigert J., Aslanidis C., Scholmerich J., et al. Innate immunity and adipocyte function: ligand-specific activation of multiple Toll-like receptors modulates cytokine, adipokine, and chemokine secretion in adipocytes. Obesity (Silver Spring) 2009, 17:648-656.
14. Aderem A., Ulevitch R.J. Toll-like receptors in the induction of the innate immune response. Nature 2000, 406:782-787.
15. Medzhitov R., Janeway C.A. Innate immunity: the virtues of a nonclonal system of recognition. Cell 1997, 91:295-298.
16. O'Neill L.A. Targeting signal transduction as a strategy to treat inflammatory diseases. Nat Rev Drug Discov 2006, 5:549-563.
17. Akira S., Takeda K. Toll-like receptor signalling. Nat Rev Immunol 2004, 4:499-511.
18. Akira S., Uematsu S., Takeuchi O. Pathogen recognition and innate immunity. Cell 2006, 124:783-801.
19. O'Neill L.A., Bowie A.G. The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling. Nat Rev Immunol 2007, 7:353-364.
20. Zhang D., Zhang G., Hayden M.S., Greenblatt M.B., Bussey C., Flavell R.A., et al. A toll-like receptor that prevents infection by uropathogenic bacteria. Science 2004, 303:1522-1526.
21. Yarovinsky F., Zhang D., Andersen J.F., Bannenberg G.L., Serhan C.N., Hayden M.S., et al. TLR11 activation of dendritic cells by a protozoan profilin-like protein. Science 2005, 308:1626-1629.
22. Shi H., Kokoeva M.V., Inouye K., Tzameli I., Yin H., Flier J.S. TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest 2006, 116:3015-3025.
23. Song M.J., Kim K.H., Yoon J.M., Kim J.B. Activation of Toll-like receptor 4 is associated with insulin resistance in adipocytes. Biochem Biophys Res Commun 2006, 346:739-745.
24. Vitseva O.I., Tanriverdi K., Tchkonia T.T., Kirkland J.L., McDonnell M.E., Apovian C.M., et al. Inducible Toll-like receptor and NF-kappaB regulatory pathway expression in human adipose tissue. Obesity (Silver Spring) 2008, 16:932-937.
25. Tsukumo D.M., Carvalho-Filho M.A., Carvalheira J.B., Prada P.O., Hirabara S.M., Schenka A.A., et al. Loss-of-function mutation in Toll-like receptor 4 prevents diet-induced obesity and insulin resistance. Diabetes 2007, 56:1986-1998.
26. Radin M.S., Sinha S., Bhatt B.A., Dedousis N., O'Doherty R.M. Inhibition or deletion of the lipopolysaccharide receptor Toll-like receptor-4 confers partial protection against lipid-induced insulin resistance in rodent skeletal muscle. Diabetologia 2008, 51:336-346.
27. Senn J.J. Toll-like receptor-2 is essential for the development of palmitate-induced insulin resistance in myotubes. J Biol Chem 2006, 281:26865-26875.
28. Murakami K., Bujo H., Unoki H., Saito Y. High fat intake induces a population of adipocytes to co-express TLR2 and TNFalpha in mice with insulin resistance. Biochem Biophys Res Commun 2007, 354:727-734.
29. Creely S.J., McTernan P.G., Kusminski C.M., Fisher M., Da Silva N.F., Khanolkar M., et al. Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes. Am J Physiol Endocrinol Metab 2007, 292:E740-E747.
30. Schaffler A., Scholmerich J., Salzberger B. Adipose tissue as an immunological organ: Toll-like receptors, C1q/TNFs and CTRPs. Trends Immunol 2007, 28:393-399.
31. Pietsch J., Batra A., Stroh T., Fedke I., Glauben R., Okur B., et al. Toll-like receptor expression and response to specific stimulation in adipocytes and preadipocytes: on the role of fat in inflammation. Ann N Y Acad Sci 2006, 1072:407-409.
32. Batra A., Pietsch J., Fedke I., Glauben R., Okur B., Stroh T., et al. Leptin-dependent toll-like receptor expression and responsiveness in preadipocytes and adipocytes. Am J Pathol 2007, 170:1931-1941.
33. Arner P. Not all fat is alike. Lancet 1998, 351:1301-1302.
34. Folch J., Lees M., Sloane Stanley G.H. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 1957, 226:497-509.
35. Choi Y.H., Kim H.I., Seong J.K., Yu D.Y., Cho H., Lee M.O., et al. Hepatitis B virus X protein modulates peroxisome proliferator-activated receptor gamma through protein-protein interaction. FEBS Lett 2004, 557:73-80.
36. Israel A. A role for phosphorylation and degradation in the control of NF-kappa B activity. Trends Genet 1995, 11:203-205.
37. Lee J.Y., Hwang D.H. The modulation of inflammatory gene expression by lipids: mediation through Toll-like receptors. Mol Cells 2006, 21:174-185.
38. Honda K., Yanai H., Mizutani T., Negishi H., Shimada N., Suzuki N., et al. Role of a transductional-transcriptional processor complex involving MyD88 and IRF-7 in Toll-like receptor signaling. Proc Natl Acad Sci U S A 2004, 101:15416-15421.
39. Honda K., Yanai H., Negishi H., Asagiri M., Sato M., Mizutani T., et al. IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature 2005, 434:772-777.
40. Kawai T., Sato S., Ishii K.J., Coban C., Hemmi H., Yamamoto M., et al. Interferon-alpha induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6. Nat Immunol 2004, 5:1061-1068.
41. Moynagh P.N. TLR signalling and activation of IRFs: revisiting old friends from the NF-kappaB pathway. Trends Immunol 2005, 26(9):469-476.
42. Negishi H., Fujita Y., Yanai H., Sakaguchi S., Ouyang X., Shinohara M., et al. Evidence for licensing of IFN-gamma-induced IFN regulatory factor 1 transcription factor by MyD88 in Toll-like receptor-dependent gene induction program. Proc Natl Acad Sci U S A 2006, 103:15136-15141.
43. Yamamoto M., Sato S., Hemmi H., Hoshino K., Kaisho T., Sanjo H., et al. Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science 2003, 301:640-643.
44. Wasserman F. Handbook of Physiology 1965, American Physiology Society, Washington, DC, USA.
45. Suganami T., Ogawa Y. J Adipose tissue macrophages: their role in adipose tissue remodeling. Leukoc Biol 2010, 88:33-39.
46. Medzhitov R., Preston-Hurlburt P., Kopp E., Stadlen A., Chen C., Ghosh S., et al. MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways. Mol Cell 1998, 2:253-258.
47. Hornung V., Rothenfusser S., Britsch S., Krug A., Jahrsdorfer B., Giese T., et al. Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J Immunol 2002, 168:4531-4537.
48. Gelman A.E., Zhang J., Choi Y., Turka L.A. Toll-like receptor ligands directly promote activated CD4+ T cell survival. J Immunol 2004, 172:6065-6073.
49. Ramis J.M., Franssen-van Hal N.L., Kramer E., Llado I., Bouillaud F., Palou A., et al. Carboxypeptidase E and thrombospondin-1 are differently expressed in subcutaneous and visceral fat of obese subjects. Cell Mol Life Sci 2002, 59:1960-1971.
50. Linder K., Arner P., Flores-Morales A., Tollet-Egnell P., Norstedt G. Differentially expressed genes in visceral or subcutaneous adipose tissue of obese men and women. J Lipid Res 2004, 45:148-154.
51. Larsson B., Bengtsson C., Bjorntorp P., Lapidus L., Sjostrom L., Svardsudd K., et al. Is abdominal body fat distribution a major explanation for the sex difference in the incidence of myocardial infarction? The study of men born in 1913 and the study of women, Goteborg, Sweden. Am J Epidemiol 1992, 135:266-273.
52. Nishimura S., Manabe I., Nagasaki M., Eto K., Yamashita H., Ohsugi M., et al. CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nat Med 2009, 15:914-920.
53. Abe M., Matsuda M., Kobayashi H., Miyata Y., Nakayama Y., Komuro R., et al. Effects of statins on adipose tissue inflammation: their inhibitory effect on MyD88-independent IRF3/IFN-beta pathway in macrophages. Arterioscler Thromb Vasc Biol 2008, 28:871-877.
54. Lee J.Y., Ye J., Gao Z., Youn H.S., Lee W.H., Zhao L., et al. Reciprocal modulation of Toll-like receptor-4 signaling pathways involving MyD88 and phosphatidylinositol 3-kinase/AKT by saturated and polyunsaturated fatty acids. J Biol Chem 2003, 278:37041-37051.
55. Krebs D.L., Hilton D.J. SOCS proteins: negative regulators of cytokine signaling. Stem Cells 2001, 19:378-387.
56. Håkansson-Ovesjö M.L., Collin M., Meister B. Down-regulated STAT3 messenger ribonucleic acid and STAT3 protein in the hypothalamic arcuate nucleus of the obese leptin-deficient (ob/ob) mouse. Endocrinology 2000, 141:3946-3955.
57. Lang J.E., Williams E.S., Mizgerd J.P., Shore S.A. Effect of obesity on pulmonary inflammation induced by acute ozone exposure: role of interleukin-6. Am J Physiol Lung Cell Mol Physiol 2008, 294:L1013-L1020.
58. Baumann H., Morella K.K., White D.W., Dembski M., Bailon P.S., Kim H., et al. The full-length leptin receptor has signaling capabilities of interleukin 6-type cytokine receptors. Proc Natl Acad Sci U S A 1996, 93:8374-8378.
59. Zhang F., Basinski M.B., Beals J.M., Briggs S.L., Churgay L.M., Clawson D.K., et al. Crystal structure of the obese protein leptin-E100. Nature 1997, 387:206-209.
60. Busso N., So A., Chobaz-Peclat V., Morard C., Martinez-Soria E., Talabot-Ayer D., et al. Leptin signaling deficiency impairs humoral and cellular immune responses and attenuates experimental arthritis. J Immunol 2002, 168:875-882.
61. Mancuso P., Gottschalk A., Phare S.M., Peters-Golden M., Lukacs N.W., Huffnagle G.B. Leptin-deficient mice exhibit impaired host defense in Gram-negative pneumonia. J Immunol 2002, 168:4018-4024.
62. Mandel M.A., Mahmoud A.A. Impairment of cell-mediated immunity in mutation diabetic mice (db/db). J Immunol 1978, 120:1375-1377.
63. Matarese G., Di Giacomo A., Sanna V., Lord G.M., Howard J.K., Di Tuoro A., et al. Requirement for leptin in the induction and progression of autoimmune encephalomyelitis. J Immunol 2001, 166:5909-5916.
64. Siegmund B., Lehr H.A., Fantuzzi G. Leptin: a pivotal mediator of intestinal inflammation in mice. Gastroenterology 2002, 122:2011-2025.